# A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

> **NCT00810589** · PHASE1 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 30 (actual)

## Conditions studied

- Diabetes, Type I

## Interventions

- **DRUG:** Levemir
- **DRUG:** Humalog NPL Insulin

## Key facts

- **NCT ID:** NCT00810589
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810589, "A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00810589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*